Individualizing Management in T2D With CKD

A leading expert provides an overview of the considerations for management of CKD associated with T2D, with a focus on pharmacotherapy options.
Vivian A. Fonseca, MD, FRCP
Format: Microsoft PowerPoint (.ppt)
File Size: 5.80 MB
Released: September 21, 2022

Acknowledgements

Provided by Clinical Care Options, LLC

Contact Clinical Care Options

For customer support please email: customersupport@cealliance.com

Mailing Address
Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA 20191

This activity is supported by independent educational grants from
Boehringer Ingelheim Pharmaceuticals, Inc. and Eli Lilly and Company
Bayer HealthCare Pharmaceuticals Inc.

Related Content

Unlocked downloadable slides featuring an overview of obesity management, including pharmacotherapy options, from Clinical Care Options (CCO)

person default Robert Kushner, MD, MS
Program Director
person default Christopher D. Still, DO, FACN, FACP
Program Director
Released: December 2, 2022

Dr Milda Saunders discusses strategies to erase health disparities in the most vulnerable patients with anemia of CKD, from Clinical Care Options (CCO)

Milda Saunders, MD, MPH Released: December 2, 2022

Concise microlearning module featuring expert insight on challenges of traditional treatment of anemia of CKD from Clinical Care Options (CCO)

person default Ajay Singh, MBBS, FRCP, MBA Physicians: maximum of 0.5 AMA PRA Category 1 Credits Registered Nurses: 0.5 Nursing contact hours Physician Assistants: 0.5 AAPA Category 1 CME credits Released: November 18, 2022 Expired: November 17, 2023

Unlocked downloadable slides featuring an overview of the challenges of traditional anemia treatment in patients with CKD, from Clinical Care Options (CCO)

Released: November 18, 2022

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue

Cookie Settings